Biogen, Inc. (BIIB)
174.45
+1.95
(+1.13%)
USD |
NASDAQ |
Dec 12, 10:08
Biogen EPS Diluted (TTM): 10.97 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Amgen, Inc. | 12.94 |
| Eli Lilly & Co. | 20.22 |
| Merck & Co., Inc. | 7.560 |
| Pfizer Inc. | 1.716 |
| Stoke Therapeutics, Inc. | 0.6599 |